Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2022 Feb;37(1):21-25.
doi: 10.1177/02683555211041931. Epub 2021 Sep 8.

Increased prevalence of deep vein thrombosis and mortality in patients with Covid-19 at a referral center in Brazil

Affiliations
Clinical Trial

Increased prevalence of deep vein thrombosis and mortality in patients with Covid-19 at a referral center in Brazil

Jose Maria Pereira de Godoy et al. Phlebology. 2022 Feb.

Abstract

Background: Among the multiple complex pathophysiological mechanisms underlying Covid-19 pneumonia, immunothrombosis has been shown to play a key role.

Objective: The aim of the present study was to assess the monthly prevalence of deep venous thrombosis in a university hospital that admitted 5159 patients with Covid-19 in the medical ward and intensive care unit (ICU) and investigate whether there has been an increase in the prevalence of deep vein thrombosis and dead recently.

Method: A clinical trial was conducted evaluating 5159 patients admitted to the university hospital, Hospital de Base in São Jose do Rio Preto-Brazil, with a positive test for Covid-19, the prevalence of monthly deep venous thrombosis and the increase in thrombotic and events and mortality in March 2020 to April 2021 compared to the previous January and February with March-April of 2021. The evaluated by Fisher's exact test.

Results: The prevalence of deep vein thrombosis varied between the months of 0.26% to 7%, with an average of 2.5%. The months of March and April 2021 had a significant increase in venous thrombosis and mortality in relation to the months of January and February 2021.

Conclusion: The prevalence of deep venous thrombosis was variable during the months evaluated, since the beginning of Covid-19, but there was a significant increase in these last two months.

Keywords: Covid-19; Prevalence; deep vein; mortality; thrombosis.

PubMed Disclaimer

Conflict of interest statement

Declaration of Conflicting Interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Figures

Figure 1.
Figure 1.
Evaluation of the total number of patients admitted to the ward and ICU with Covid-19.
Figure 2.
Figure 2.
Variations in monthly prevalence’s of deep vein thrombosis and mortality.

References

    1. Wu MA, Colombo R, Arquati M, et al.. Clinical-radiological correlations in COVID-19-related venous thromboembolism: preliminary results from a multidisciplinary study. Int J Clin Pract 2021; 17: e14370. doi: 10.1111/ijcp.14370. - PMC - PubMed
    1. Stark K, Massberg S. Interplay between inflammation and thrombosis in cardiovascular pathology. Nat Rev Cardiol 2021; 18: 666–682. doi:10.1038/s41569-021-00552-1. - PMC - PubMed
    1. Nicolai L, Leunig A, Brambs S, et al.. Immunothrombotic dysregulation in COVID-19 pneumonia is associated with respiratory failure and coagulopathy. Circulation 2020; 142: 1176–1189. - PMC - PubMed
    1. García-Ceberino PM, Faro-Míguez N, Beltrán-Ávila FJ, et al.. Point of care ultrasound (POCUS) in diagnosis of proximal deep vein thrombosis among COVID-19 hospitalized patients with a high rate of low molecular weight heparin prophylaxis. Med Clin (Barc) 2021; 27: S0025-7753(21)00090–7. doi: 10.1016/j.medcli.2021.01.012. - PMC - PubMed
    1. Longchamp G, Manzocchi-Besson S, Longchamp A, et al.. Proximal deep vein thrombosis and pulmonary embolism in COVID-19 patients: a systematic review and meta-analysis. Thromb J 2021; 19: 15. - PMC - PubMed

Publication types